Annual D&A
$735.00 K
-$104.00 K-12.40%
December 31, 2023
Summary
- As of February 7, 2025, YMAB annual depreciation & amortization is $735.00 thousand, with the most recent change of -$104.00 thousand (-12.40%) on December 31, 2023.
- During the last 3 years, YMAB annual D&A has risen by +$339.00 thousand (+85.61%).
- YMAB annual D&A is now -12.40% below its all-time high of $839.00 thousand, reached on December 31, 2022.
Performance
YMAB Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$121.00 K
-$32.00 K-20.92%
September 30, 2024
Summary
- As of February 7, 2025, YMAB quarterly depreciation & amortization is $121.00 thousand, with the most recent change of -$32.00 thousand (-20.92%) on September 30, 2024.
- Over the past year, YMAB quarterly D&A has dropped by -$40.00 thousand (-24.84%).
- YMAB quarterly D&A is now -58.42% below its all-time high of $291.00 thousand, reached on December 31, 2021.
Performance
YMAB Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$594.00 K
-$47.00 K-7.33%
September 30, 2024
Summary
- As of February 7, 2025, YMAB TTM depreciation & amortization is $594.00 thousand, with the most recent change of -$47.00 thousand (-7.33%) on September 30, 2024.
- Over the past year, YMAB TTM D&A has dropped by -$141.00 thousand (-19.18%).
- YMAB TTM D&A is now -34.00% below its all-time high of $900.00 thousand, reached on September 30, 2022.
Performance
YMAB TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
YMAB Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -12.4% | -24.8% | -19.2% |
| 3 y3 years | +85.6% | -47.4% | -29.2% |
| 5 y5 years | +2434.5% | -47.4% | -29.2% |
YMAB Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -12.4% | at low | -58.4% | at low | -34.0% | at low |
| 5 y | 5-year | -12.4% | +342.8% | -58.4% | +53.2% | -34.0% | +257.8% |
| alltime | all time | -12.4% | -100.0% | -58.4% | -100.0% | -34.0% | -100.0% |
Y-mAbs Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $121.00 K(-20.9%) | $594.00 K(-7.3%) |
| Jun 2024 | - | $153.00 K(-3.8%) | $641.00 K(-10.0%) |
| Mar 2024 | - | $159.00 K(-1.2%) | $712.00 K(-3.1%) |
| Dec 2023 | $735.00 K(-12.4%) | $161.00 K(-4.2%) | $735.00 K(-8.6%) |
| Sep 2023 | - | $168.00 K(-25.0%) | $804.00 K(-6.7%) |
| Jun 2023 | - | $224.00 K(+23.1%) | $862.00 K(+4.4%) |
| Mar 2023 | - | $182.00 K(-20.9%) | $826.00 K(-1.5%) |
| Dec 2022 | $839.00 K(+7.3%) | $230.00 K(+1.8%) | $839.00 K(-6.8%) |
| Sep 2022 | - | $226.00 K(+20.2%) | $900.00 K(+9.9%) |
| Jun 2022 | - | $188.00 K(-3.6%) | $819.00 K(-3.3%) |
| Mar 2022 | - | $195.00 K(-33.0%) | $847.00 K(+8.3%) |
| Dec 2021 | $782.00 K | $291.00 K(+100.7%) | $782.00 K(+28.6%) |
| Sep 2021 | - | $145.00 K(-32.9%) | $608.00 K(+9.4%) |
| Jun 2021 | - | $216.00 K(+66.2%) | $556.00 K(+26.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $130.00 K(+11.1%) | $440.00 K(+11.1%) |
| Dec 2020 | $396.00 K(+138.6%) | $117.00 K(+25.8%) | $396.00 K(+10.6%) |
| Sep 2020 | - | $93.00 K(-7.0%) | $358.00 K(+14.4%) |
| Jun 2020 | - | $100.00 K(+16.3%) | $313.00 K(+34.3%) |
| Mar 2020 | - | $86.00 K(+8.9%) | $233.00 K(+40.4%) |
| Dec 2019 | $166.00 K(+472.4%) | $79.00 K(+64.6%) | $166.00 K(+64.4%) |
| Sep 2019 | - | $48.00 K(+140.0%) | $101.00 K(+62.9%) |
| Jun 2019 | - | $20.00 K(+5.3%) | $62.00 K(+29.2%) |
| Mar 2019 | - | $19.00 K(+35.7%) | $48.00 K(+65.5%) |
| Dec 2018 | $29.00 K(>+9900.0%) | $14.00 K(+55.6%) | $29.00 K(+93.3%) |
| Sep 2018 | - | $9000.00(+50.0%) | $15.00 K(+150.0%) |
| Jun 2018 | - | $6000.00(>+9900.0%) | $6000.00(>+9900.0%) |
| Mar 2018 | - | $0.00 | $0.00 |
| Dec 2017 | $0.00(0.0%) | - | - |
| Dec 2016 | $0.00 | - | - |
FAQ
- What is Y-mAbs Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics annual D&A year-on-year change?
- What is Y-mAbs Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics quarterly D&A year-on-year change?
- What is Y-mAbs Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics TTM D&A year-on-year change?
What is Y-mAbs Therapeutics annual depreciation & amortization?
The current annual D&A of YMAB is $735.00 K
What is the all time high annual D&A for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high annual depreciation & amortization is $839.00 K
What is Y-mAbs Therapeutics annual D&A year-on-year change?
Over the past year, YMAB annual depreciation & amortization has changed by -$104.00 K (-12.40%)
What is Y-mAbs Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of YMAB is $121.00 K
What is the all time high quarterly D&A for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high quarterly depreciation & amortization is $291.00 K
What is Y-mAbs Therapeutics quarterly D&A year-on-year change?
Over the past year, YMAB quarterly depreciation & amortization has changed by -$40.00 K (-24.84%)
What is Y-mAbs Therapeutics TTM depreciation & amortization?
The current TTM D&A of YMAB is $594.00 K
What is the all time high TTM D&A for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high TTM depreciation & amortization is $900.00 K
What is Y-mAbs Therapeutics TTM D&A year-on-year change?
Over the past year, YMAB TTM depreciation & amortization has changed by -$141.00 K (-19.18%)